Table 2.
Formula for 1 tablet (200 mg) for the optimization of Polyvinylpyrrolidone K-30 or Microcrystalline Cellulose with optimized concentration of Sodium Starch Glycolate.
| Formula number | Contents | |||||||
|---|---|---|---|---|---|---|---|---|
| Cetirizine Hydrochloride (mg) | SSG (mg) | PVP K-30 (mg) | MCC (mg) | Sodium Stearyl Fumarate (mg) | Talc (mg) | Sodium Saccharin (mg) | Mannitol (mg) | |
| F1 | 5 | 8 | 2 | — | 2 | 2 | 5 | 176 |
| F2 | 5 | 8 | 4 | — | 2 | 2 | 5 | 174 |
| F3 | 5 | 8 | 6 | — | 2 | 2 | 5 | 172 |
| F4 | 5 | 8 | 8 | — | 2 | 2 | 5 | 170 |
| F5 | 5 | 8 | 10 | — | 2 | 2 | 5 | 168 |
| F6 | 5 | 8 | 12 | — | 2 | 2 | 5 | 166 |
| F7 | 5 | 8 | 14 | 2 | 2 | 5 | 164 | |
| F8 | 5 | 8 | — | 2 | 2 | 2 | 5 | 176 |
| F9 | 5 | 8 | — | 4 | 2 | 2 | 5 | 174 |
| F10 | 5 | 8 | — | 6 | 2 | 2 | 5 | 172 |
| F11 | 5 | 8 | — | 8 | 2 | 2 | 5 | 170 |
| F12 | 5 | 8 | — | 10 | 2 | 2 | 5 | 168 |
| F13 | 5 | 8 | — | 12 | 2 | 2 | 5 | 166 |
| F14 | 5 | 8 | — | 14 | 2 | 2 | 5 | 164 |